Skip to Main Content

Author Details

Elton Rexhepaj
UCD Conway Institute, University College Dublin
2007
30
23
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35332319Author Correction: Antibody-based proteomics: fast-tracking molecular diagnostics in oncology.Nat Rev Cancer2022
35332319Author Correction: Antibody-based proteomics: fast-tracking molecular diagnostics in oncology.Nat Rev Cancer2022
34214188QUAREP-LiMi: A community-driven initiative to establish guidelines for quality assessment and reproducibility for instruments and images in light microscopy.J Microsc2021
34214188QUAREP-LiMi: A community-driven initiative to establish guidelines for quality assessment and reproducibility for instruments and images in light microscopy.J Microsc2021
29100480Compound Functional Prediction Using Multiple Unrelated Morphological Profiling Assays.SLAS Technol2018
29100480Compound Functional Prediction Using Multiple Unrelated Morphological Profiling Assays.SLAS Technol2018
28561033Smooth 2D manifold extraction from 3D image stack.Nat Commun2017
28561033Smooth 2D manifold extraction from 3D image stack.Nat Commun2017
26541534Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.Eur Respir J2015
26541534Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.Eur Respir J2015
23569271Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model.Proc Natl Acad Sci U S A2013
23690928A texture based pattern recognition approach to distinguish melanoma from non-melanoma cells in histopathological tissue microarray sections.PLoS One2013
23435261Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells.Nat Methods2013
23547718Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.BMC Cancer2013
23569271Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model.Proc Natl Acad Sci U S A2013
23690928A texture based pattern recognition approach to distinguish melanoma from non-melanoma cells in histopathological tissue microarray sections.PLoS One2013
23435261Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells.Nat Methods2013
23547718Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.BMC Cancer2013
22139072The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer.Oncogene2012
22139072The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer.Oncogene2012
20972749Tissue microarrays and digital image analysis.Methods Mol Biol2011
20972749Tissue microarrays and digital image analysis.Methods Mol Biol2011
21240253Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.Mod Pathol2011
21677534SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.Am J Surg Pathol2011
21804916RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer.Transl Oncol2011
22039576Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.Cancer Discov2011
21999197Identification of a myometrial molecular profile for dystocic labor.BMC Pregnancy Childbirth2011
21795409Interleukin-6 as a therapeutic target in human ovarian cancer.Clin Cancer Res2011
21943380The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.BMC Cancer2011
21999197Identification of a myometrial molecular profile for dystocic labor.BMC Pregnancy Childbirth2011
22039576Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.Cancer Discov2011
21804916RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer.Transl Oncol2011
21795409Interleukin-6 as a therapeutic target in human ovarian cancer.Clin Cancer Res2011
21943380The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.BMC Cancer2011
21677534SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.Am J Surg Pathol2011
21240253Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.Mod Pathol2011
20359358Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer.BMC Cancer2010
20890226SOX10 expression in superficial spreading and nodular malignant melanomas.Melanoma Res2010
20720569Antibody-based proteomics: fast-tracking molecular diagnostics in oncology.Nat Rev Cancer2010
20924104Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.Cancer Res2010
21092276Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.BMC Cancer2010
20359358Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer.BMC Cancer2010
21092276Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.BMC Cancer2010
20720569Antibody-based proteomics: fast-tracking molecular diagnostics in oncology.Nat Rev Cancer2010
20924104Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.Cancer Res2010
20890226SOX10 expression in superficial spreading and nodular malignant melanomas.Melanoma Res2010
19714869Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma.J Proteome Res2009
19714869Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma.J Proteome Res2009
18451232Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.Clin Cancer Res2008
18479893Creation of a digital slide and tissue microarray resource from a multi-institutional predictive toxicology study in the rat: an initial report from the PredTox group.Exp Toxicol Pathol2008
  • 1 - 50 of 60

Recommended Authors

Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Career Start Year 2013
Number of shared co-authors 0
Juan Moreno
University of Toronto
Career Start Year 2011
Number of shared co-authors 0
Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 0
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 16
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 1
Samuel Leung
University of British Columbia
Career Start Year 2007
Number of shared co-authors 2
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 2
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 0
Daisuke Komura
Graduate School of Medicine, The University of Tokyo
Career Start Year 2005
Number of shared co-authors 0
Nathalie Pochet
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 0
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 3
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 1
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 0
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 2
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 0
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 0
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 7
Patrick Micke
Uppsala University
Career Start Year 1997
Number of shared co-authors 18
Robert Kim
University of California
Career Start Year 1996
Number of shared co-authors 0
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Career Start Year 1995
Number of shared co-authors 2
Jeroen A W M van der Laak
Radboud University Medical Center
Career Start Year 1994
Number of shared co-authors 2
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 1
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 1
John M S Bartlett
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 5
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 4
Beatrice S Knudsen
University of Utah
Career Start Year 1986
Number of shared co-authors 0
David L Rimm
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 5
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers 23
Donal J Brennan
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Co-authored papers 17
Karin Jirstr??m
Lund University
Co-authored papers 13
Fredrik Pont??n
Uppsala University
Co-authored papers 10
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers 9
Darran P O'Connor
UCD Conway Institute, University College Dublin
Co-authored papers 8
Emma Lundberg (CM4AI)
Stanford University
Co-authored papers 5
Margr??t Agnarsd??ttir
Uppsala University
Co-authored papers 3
Sharon F McGee
The Ottawa Hospital Cancer Centre
Co-authored papers 3
Elaine Del Nery
Co-authored papers 3
Michael Bergqvist
Umea University
Co-authored papers 3
Catherine M Kelly
Mater Misericordiae University Hospital
Co-authored papers 2
Robert C Millikan
Co-authored papers 2
Denise Ryan
UCD Conway Institute, University College Dublin
Co-authored papers 2
Carl A K Borrebaeck
Lund University
Co-authored papers 2
Anders Bjartell
Skane University Hospital, Lund University
Co-authored papers 2
Aedin C Culhane
Dana-Farber Cancer Institute & Harvard School of Public Health
Co-authored papers 2
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Sara Str??mberg
Uppsala University
Co-authored papers 2
Asa Bolander
Uppsala University
Co-authored papers 2
Kristina Magnusson
Uppsala University
Co-authored papers 2
Anna Asplund
Uppsala University
Co-authored papers 2
Louis Banka Johnson
Skane University Hospital - Malmo, Lund University
Co-authored papers 1
Andrea Bassi
Co-authored papers 1
Gerhard Holst
Co-authored papers 1
Tobias Mueller
Co-authored papers 1
Daniel Klevebring
Karolinska Institutet
Co-authored papers 1
Antje Keppler
Co-authored papers 1
Patrick C O'Leary
University of California San Francisco
Co-authored papers 1
Johanna Bischof
Co-authored papers 1
Release 1.2